Clinical Trial Update: A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II study of neoadjuvant immunotherapy in combination with chemotherapy for locally advanced head and neck squamous cell carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Lei Liu | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING